CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $225,530
- in 2 filings, $226K under 10b5-1 plans
Net −$225,530. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-08 | Sank Leonard Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-08 | RAKIN KEVIN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-08 | Mayer Arie Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-08 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +190,000 | 190,000 | ||
| 2020-01-08 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-01-08 | Xiaoming Gao Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-01-08 | Friedman Aviad Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-09-12 | RAKIN KEVIN Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2019-09-12 | KIDRON NADAV President and CEO | Grant or award · Stock Option (right to buy) | +196,500 | 196,500 | ||
| 2019-09-12 | Kidron Miriam Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +104,000 | 104,000 | ||
| 2019-09-12 | Gabay Avraham CFO, Treasurer and Secretary | Grant or award · Stock Option (right to buy) | +33,146 | 33,146 | ||
| 2019-09-12 | Hexter Joshua Chf. Op. & Bus. Officer | Grant or award · Stock option (right to buy) | +100,000 | 100,000 | ||
| 2019-09-09 | Sank Leonard Director | Purchase | +15,000 | $2.90 | $44K | 364,999 |
| 2019-09-09 | Sank Leonard Director | Purchase | +10,000 | $2.95 | $30K | 374,999 |
| 2019-07-18 | Sank Leonard Director | Purchase | +4,497 | $3.86 | $17K | 349,999 |
| 2019-07-17 | Sank Leonard Director | Purchase | +20,000 | $3.58 | $72K | 335,482 |
| 2019-07-17 | Sank Leonard Director | Purchase | +10,020 | $3.74 | $37K | 345,502 |
| 2019-07-16 | Sank Leonard Director | Purchase | +20,000 | $3.47 | $69K | 315,482 |
| 2019-07-11 | Sank Leonard Director | Purchase | +1,320 | $3.22 | $4K | 295,482 |
| 2019-06-17 | Gabay Avraham CFO, Treasurer and Secretary | Returned to the company · Stock Option (right to buy) | −33,146 | 0 |
Page 13 of 18 · 349 trades